The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma | The George Washington University School of Medicine and Health Sciences

GWCC Grand Rounds

The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma

Presenter

Julio Chavez, MD, MS
Associate Member
Lymphoma Section of the Department of Malignant Hematology
Moffitt Cancer Center

Session date:

04/11/2025 - 8:00am to 9:00am EDT

Location:

Virtual Meeting

United States

See map: Google Maps

Add to calendar:

1.00 AMA PRA Category 1 Credit™
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
1.00 Completion

Please login or register to take this course.